A single-dose COVID-19 vaccine Sputnik Light last week received authorization for use in Russia, the Russian Health Ministry together with the jab’s developer and the sponsor has announced.
Data collected from 28 days after the injection showed that the vaccine has 79.4 percent efficacy, a joint statement said. The Sputnik Light has proven effective against all new strains of the coronavirus and has demonstrated no serious side-effects, said Russia’s Gamaleya National Research Center of Epidemiology and Microbiology, which developed the jab. The Phase III clinical study involving 7,000 people is being conducted in multiple countries, including Russia, the United Arab Emirates and Ghana, and the interim results are expected later this month.
According to the statement, the Sputnik Light will cost less than 10 U.S. dollars globally, and it features easy storage and logistics. “The Sputnik Light offers strong value in initial vaccination and re-vaccination, as well as boosting efficacy when taken in combination with other vaccines,” said Alexander Gintsburg, director of the Gamaleya center. Russia has already registered Sputnik V, EpiVacCorona and CoviVac vaccines against the coronavirus. The country has also started mass production of the world’s first COVID-19 vaccine for animals Carnivac-Cov.
There’s no story that cannot be told. We cover the stories that others don’t want to be told, we bring you all the news you need. If you have tips, exposes or any story you need to be told bluntly and all queries write to us [email protected] also find us on twitter.